0,807  0,004  Cardiovascular analeptic
0,804  0,015  Antiinflammatory
0,729  0,020  Caspase 9 stimulant
0,688  0,009  Sensitization
0,676  0,003  Contraceptive
0,687  0,015  TNF expression inhibitor
0,677  0,018  Teratogen
0,670  0,015  CYP2C9 substrate
0,664  0,013  Respiratory analeptic
0,654  0,012  Aldehyde oxidase inhibitor
0,648  0,008  AR expression inhibitor
0,661  0,022  CYP3A4 substrate
0,647  0,019  Embryotoxic
0,629  0,002  Cushing's syndrome treatment
0,631  0,010  UGT1A9 substrate
0,621  0,010  NOS3 expression inhibitor
0,622  0,012  CTGF expression inhibitor
0,647  0,040  Apoptosis agonist
0,611  0,010  Antipruritic, allergic
0,603  0,011  Cytostatic
0,608  0,017  Mood disorders treatment
0,604  0,014  CYP2C19 substrate
0,589  0,002  Lipocortins synthesis antagonist
0,595  0,009  UGT1A6 substrate
0,593  0,008  Metabolic disease treatment
0,585  0,004  Endometrios treatment
0,587  0,012  Hepatic disorders treatment
0,572  0,007  UGT1A4 substrate
0,571  0,016  Analeptic
0,590  0,036  Antineoplastic (breast cancer)
0,569  0,023  Cholesterol antagonist
0,551  0,005  UGT2B4 substrate
0,517  0,003  Contraceptive male
0,516  0,004  Abortion inducer
0,516  0,004  Interleukin 6 antagonist
0,516  0,005  Sulfotransferase substrate
0,525  0,016  NOS2 expression inhibitor
0,512  0,004  UGT2B15 substrate
0,526  0,024  Antidepressant
0,500  0,007  Prostatic (benign) hyperplasia treatment
0,507  0,021  Antineoplastic (pancreatic cancer)
0,495  0,012  UDP-glucuronosyltransferase substrate
0,508  0,031  Immunosuppressant
0,518  0,042  Transcription factor NF kappa B inhibitor
0,480  0,006  UGT2B7 substrate
0,477  0,003  Contraceptive female
0,483  0,013  Antihypertriglyceridemic
0,481  0,011  Antineoplastic (liver cancer)
0,487  0,028  Antihypercholesterolemic
0,464  0,009  Hair growth stimulant
0,459  0,004  Antipruritic, non-allergic
0,458  0,007  Antiacne
0,454  0,008  Prostate disorders treatment
0,444  0,008  Sodium/bile acid cotransporter inhibitor
0,447  0,012  Anesthetic general
0,443  0,009  Anesthetic
0,446  0,013  Antimutagenic
0,430  0,004  Postmenopausal disorders treatment
0,437  0,014  UGT1A1 substrate
0,420  0,004  UGT2B9 substrate
0,439  0,039  Bone diseases treatment
0,409  0,010  Interferon gamma antagonist
0,403  0,012  Melanin inhibitor
0,394  0,009  Pneumotoxic
0,416  0,032  Antioxidant
0,410  0,027  Chemopreventive
0,416  0,034  Antiosteoporotic
0,401  0,025  Nitric oxide antagonist
0,403  0,032  Carcinogenic
0,434  0,063  Antibacterial
0,378  0,013  Carcinogenic, group 3
0,405  0,042  CYP2D6 substrate
0,392  0,030  Proliferative diseases treatment
0,364  0,003  SULT1A1 substrate
0,367  0,008  Neurotrophic factor enhancer
0,359  0,007  Psychosexual dysfunction treatment
0,403  0,051  Prostate cancer treatment
0,391  0,041  CYP1A2 substrate
0,378  0,034  Calcium channel activator
0,374  0,032  Antihypoxic
0,341  0,005  Estrogen antagonist
0,374  0,039  Cytotoxic
0,393  0,067  Antineoplastic (lung cancer)
0,375  0,050  ICAM1 expression inhibitor
0,321  0,005  Estrogen agonist
0,317  0,005  Estrogen receptor beta antagonist
0,316  0,010  Toxic, respiratory center
0,339  0,038  Antineoplastic (endocrine cancer)
0,325  0,024  Antiviral (Influenza)
0,303  0,005  Aromatase inhibitor
0,301  0,005  UGT2B10 substrate
0,342  0,048  Hypoxia-inducible factor 1 alpha inhibitor
0,301  0,007  Androgen antagonist
0,313  0,019  Urolithiasis treatment
0,297  0,004  Progesterone antagonist
0,306  0,016  Antiviral (Influenza A)
0,320  0,036  GST M1-1 substrate
0,295  0,011  Antifungal enhancer
0,316  0,039  Antiparasitic
0,327  0,050  Chemoprotective
0,295  0,017  Genotoxic
0,277  0,003  Arachidonic acid antagonist
0,297  0,024  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,293  0,022  UGT1A3 substrate
0,355  0,085  GST A substrate
0,299  0,029  P-glycoprotein inhibitor
0,283  0,025  Diuretic
0,301  0,044  5 Hydroxytryptamine uptake stimulant
0,256  0,002  RNA-directed RNA polymerase stimulant
0,283  0,031  VCAM1 expression inhibitor
0,252  0,006  Growth stimulant
0,289  0,046  Mutagenic
0,247  0,004  Androgen agonist
0,247  0,006  Estrogen receptor alpha antagonist
0,278  0,039  Antihypotensive
0,236  0,002  UGT2B11 substrate
0,241  0,010  Antirickettsial
0,270  0,040  RNA-directed DNA polymerase inhibitor
0,322  0,092  Antileukemic
0,242  0,014  Carcinogenic, group 2B
0,255  0,029  Tumour necrosis factor antagonist
0,225  0,002  Anabolic
0,224  0,004  Aldosterone antagonist
0,228  0,011  Menstruation disorders treatment
0,271  0,055  DNA synthesis inhibitor
0,226  0,010  Antineoplastic, alkylator
0,277  0,061  Urologic disorders treatment
0,242  0,027  Antipruritic
0,250  0,037  Eye irritation, high
0,215  0,002  Progesterone agonist
0,231  0,018  Phobic disorders treatment
0,233  0,021  Antihyperlipoproteinemic
0,255  0,043  Antihelmintic
0,215  0,005  SULT1E1 substrate
0,212  0,004  Premenstrual syndrome treatment
0,209  0,003  Glucocorticoid antagonist
0,217  0,011  Coagulant
0,215  0,013  Movement disorders treatment
0,233  0,031  Protein kinase stimulant
0,269  0,067  Antineoplastic (cervical cancer)
0,245  0,045  Hepatoprotectant
0,282  0,087  Interleukin 2 agonist
0,199  0,005  Estrogen receptor beta agonist
0,310  0,117  CYP2C19 inhibitor
0,225  0,035  LDLR expression enhancer
0,205  0,016  Alcohol dehydrogenase substrate
0,204  0,015  UGT2B1 substrate
0,221  0,034  NOS3 expression enhancer
0,189  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,203  0,019  Microtubule formation inhibitor
0,270  0,087  Antiepileptic
0,324  0,143  Cyclophilin D inhibitor
0,324  0,143  Antidiabetic
0,253  0,074  Tumour necrosis factor alpha release inhibitor
0,197  0,018  Choleretic
0,193  0,017  Adenylate cyclase stimulant
0,191  0,016  Antineoplastic alkaloid
0,178  0,003  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,200  0,027  Cholesterol synthesis inhibitor
0,194  0,023  Farnesoid X receptor antagonist
0,180  0,010  Keratolytic
0,185  0,015  HDL-cholesterol increasing
0,210  0,042  VEGF expression inhibitor
0,273  0,106  Apoptosis antagonist
0,190  0,023  Antineoplastic antibiotic
0,172  0,005  Estrogen receptor alpha agonist
0,198  0,031  SULT1A3 substrate
0,170  0,005  Mineralocorticoid receptor antagonist
0,283  0,118  Ulceration
0,226  0,063  Antialcoholic
0,181  0,019  Interleukin 8 antagonist
0,172  0,012  Ca2+-transporting ATPase inhibitor
0,162  0,003  Postcoital contraceptive
0,238  0,079  Antineoplastic (sarcoma)
0,189  0,032  DNA polymerase I inhibitor
0,238  0,081  Tyrosine 3 hydroxylase inhibitor
0,174  0,018  Antispirochetal
0,246  0,091  5 Hydroxytryptamine release stimulant
0,267  0,112  FMO1 substrate
0,197  0,043  Lipid peroxidase inhibitor
0,222  0,071  Antiparkinsonian, rigidity relieving
0,183  0,036  Neurotrophic factor
0,169  0,023  Mucolytic
0,178  0,032  Antieczematic
0,237  0,095  Gastrin inhibitor
0,275  0,134  GABA C receptor rho-3 antagonist
0,154  0,013  Paget's disease treatment
0,254  0,113  Antineoplastic (osteosarcoma)
0,218  0,078  Peptidyltransferase inhibitor
0,237  0,098  Lipoprotein disorders treatment
0,233  0,094  Flavin-containing monooxygenase substrate
0,157  0,019  Posttraumatic stress disorder treatment
0,236  0,100  Radiosensitizer
0,169  0,034  Glutathione S-transferase substrate
0,165  0,031  Pregnane X receptor agonist
0,163  0,030  Expectorant
0,166  0,034  Autism spectrum disorders treatment
0,166  0,036  Adenylate cyclase inhibitor
0,131  0,003  SULT2A1 substrate
0,228  0,105  Renal disease treatment
0,227  0,106  Radioprotector
0,200  0,080  Age-related macular degeneration treatment
0,138  0,019  Opioid kappa receptor antagonist
0,158  0,040  Antitussive
0,161  0,044  Skin irritative effect
0,210  0,094  Antineoplastic (glioma)
0,158  0,044  Monophenol monooxygenase inhibitor
0,124  0,011  Narcotic antagonist
0,122  0,008  5-Alpha-reductase inhibitor
0,122  0,010  Anticholelithogenic
0,116  0,004  Antihyperaldosteronism
0,200  0,089  Nitric-oxide synthase stimulant
0,125  0,015  Glycine receptor antagonist
0,113  0,004  Lipocortins synthesis agonist
0,138  0,029  Creatine kinase inhibitor
0,123  0,015  Na+ K+ transporting ATPase inhibitor
0,195  0,088  Antineoplastic (glioblastoma multiforme)
0,126  0,020  Tocolytic
0,113  0,008  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,216  0,111  Antineoplastic (ovarian cancer)
0,138  0,033  UDP-glucose 4-epimerase inhibitor
0,135  0,031  Toll-Like receptor 4 antagonist
0,126  0,023  Antiviral (Trachoma)
0,106  0,004  Hypogonadism treatment
0,227  0,126  FMO3 substrate
0,211  0,111  Interleukin agonist
0,227  0,127  Antifungal
0,103  0,003  Pregnane X receptor antagonist
0,153  0,053  Alpha-N-acetylglucosaminidase inhibitor
0,148  0,052  Antiprotozoal (Trichomonas)
0,172  0,077  Succinate dehydrogenase inhibitor
0,161  0,067  Hexokinase inhibitor
0,131  0,038  Antiinfertility, female
0,122  0,031  Actinic keratosis treatment
0,142  0,051  Alkylator
0,184  0,094  Interleukin antagonist
0,116  0,028  Ornithine decarboxylase inhibitor
0,151  0,065  Antiparkinsonian, tremor relieving
0,141  0,056  Antihemorrhagic
0,112  0,029  Antibiotic
0,161  0,078  Muscular dystrophy treatment
0,194  0,113  Antipyretic
0,149  0,069  Antidiabetic (type 1)
0,193  0,113  Heart failure treatment
0,094  0,015  Antimycoplasmal
0,158  0,080  Sigma receptor agonist
0,119  0,041  GST T1-1 substrate
0,185  0,110  Antiprotozoal (Leishmania)
0,120  0,045  DOPA decarboxylase inhibitor
0,095  0,020  Antitreponemal
0,086  0,012  Heme oxygenase stimulant
0,104  0,031  Antiprotozoal activity enhancer
0,121  0,049  GABA C receptor agonist
0,134  0,063  Cyclooxygenase 3 inhibitor
0,117  0,050  Nav1.1 sodium channel blocker
0,168  0,101  CYP2B6 inhibitor
0,190  0,124  DNA damaging
0,078  0,013  Potassium channel Kv1.3 blocker
0,132  0,070  Cocaine dependence treatment
0,068  0,005  Estrone sulfatase inhibitor
0,081  0,019  Hypercalcemia treatment
0,156  0,095  Phospholipase C inhibitor
0,118  0,058  GABA receptor agonist
0,104  0,045  Opioid antagonist
0,066  0,006  5-Alpha-reductase 2 inhibitor
0,153  0,095  ATPase inhibitor
0,107  0,049  Prolactin inhibitor
0,129  0,073  CC chemokine 6 receptor antagonist
0,121  0,065  Antiviral (Influenza B)
0,182  0,127  Vascular (periferal) disease treatment
0,100  0,045  Antidote, mercury
0,087  0,033  Antidote, organophosphates
0,071  0,017  Ryanodine receptor antagonist
0,095  0,042  GABA A receptor agonist
0,088  0,035  SULT1A2 substrate
0,060  0,007  Glucose-6-phosphate dehydrogenase inhibitor
0,058  0,007  5-Alpha-reductase 1 inhibitor
0,061  0,010  GABA uptake inhibitor
0,056  0,004  Glucocorticoid agonist
0,262  0,211  5 Hydroxytryptamine release inhibitor
0,067  0,017  Anesthetic inhalation
0,111  0,062  GABA C receptor antagonist
0,152  0,104  Sedative
0,063  0,016  Adenylate cyclase 1 inhibitor
0,083  0,035  Glycine receptor agonist
0,121  0,073  Antiseptic
0,075  0,028  Andropause treatment
0,089  0,042  Estrogen-related receptor beta agonist
0,125  0,078  Skin whitener
0,088  0,042  T cell inhibitor
0,074  0,028  Argininosuccinate synthase inhibitor
0,113  0,067  Photosensitizer
0,207  0,163  Antihypertensive
0,047  0,003  Corticosteroid-like
0,068  0,025  Protein 50S ribosomal subunit inhibitor
0,173  0,131  Antineoplastic (renal cancer)
0,134  0,093  Antiviral (Herpes)
0,049  0,009  Vanilloid 3 antagonist
0,083  0,044  Analgesic, opioid
0,115  0,076  Antifungal (Pneumocystis)
0,096  0,057  Bile acid receptor antagonist
0,093  0,055  Triose-phosphate isomerase inhibitor
0,163  0,125  Hypolipemic
0,044  0,006  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,046  0,009  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,066  0,031  Alcohol oxidase inhibitor
0,111  0,077  Antineoplastic antimetabolite
0,101  0,069  AMP-activated protein kinase stimulant
0,120  0,088  Vanilloid 1 agonist
0,037  0,005  Hedgehog signaling activator
0,035  0,004  Progesterone receptor B antagonist
0,163  0,132  Antineoplastic enhancer
0,042  0,012  ATP citrate lysase inhibitor
0,173  0,143  Antineoplastic (colon cancer)
0,180  0,150  Antineoplastic (colorectal cancer)
0,077  0,048  Glutamate dehydrogenase inhibitor
0,199  0,170  Caspase 3 stimulant
0,110  0,082  Aldehyde dehydrogenase inhibitor
0,174  0,147  Antineoplastic (melanoma)
0,174  0,149  Superoxide dismutase inhibitor
0,089  0,065  Glutamate release inhibitor
0,075  0,052  Porphobilinogen synthase inhibitor
0,026  0,003  Progesterone receptor A antagonist
0,159  0,137  Cyclic AMP phosphodiesterase inhibitor
0,051  0,029  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,068  0,047  Opioid mu receptor antagonist
0,025  0,004  Telomerase stimulant
0,022  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,055  0,037  GABA receptor antagonist
0,085  0,068  Potassium channel activator
0,119  0,101  Peroxidase inhibitor
0,026  0,009  Vitamin D receptor antagonist
0,143  0,127  Angiogenesis stimulant
0,067  0,050  Phosphofructokinase-1 inhibitor
0,113  0,097  Cytokine production inhibitor
0,128  0,111  Muscle relaxant
0,045  0,028  Opioid kappa receptor agonist
0,047  0,031  Microtubule stabilization
0,036  0,020  Tubulin agonist
0,017  0,001  Transcortin receptor antagonist
0,092  0,077  Topoisomerase I inhibitor
0,026  0,011  GRP78 expression inhibitor
0,195  0,182  Vasodilator, peripheral
0,078  0,066  Inducible nitric-oxide synthase inhibitor
0,021  0,009  Antibiotic Anthracycline-like
0,017  0,006  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,051  0,040  GABA A receptor antagonist
0,079  0,069  Antiviral (Dengue virus)
0,023  0,014  Retinoic acid gamma receptor agonist
0,074  0,065  MAP kinase kinase 7 inhibitor
0,046  0,037  Glucose-6-phosphate isomerase inhibitor
0,128  0,119  Uterine stimulant
0,081  0,073  NADH dehydrogenase inhibitor
0,016  0,009  Antibiotic Tetracycline-like
0,095  0,088  Anesthetic local
0,066  0,058  Dysmenorrhea treatment
0,017  0,010  Vitamin D receptor agonist
0,035  0,029  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,092  0,087  Cystathionine beta-synthase inhibitor
0,191  0,186  CYP3A4 inhibitor
0,020  0,015  Retinoic acid alpha receptor antagonist
0,112  0,108  Nav1.6 sodium channel blocker
0,100  0,097  Amylase inhibitor
0,109  0,107  Acaricide
0,019  0,018  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,043  0,042  Cholesterol esterase inhibitor

